These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 39031273)

  • 1. Paraneoplastic glomerulonephritis and kidney infiltration by mantle cell lymphoma: A diagnostic challenge.
    Lerma-Verdejo A; Monroy-Condori M; Guerra-Torres XE; Paredes NDM; Egea AS; Díaz F; Morales-Montoya JL; Vega JG; Arenas-Moncaleano I; Ramos FS
    J Hematop; 2024 Dec; 17(4):237-244. PubMed ID: 39031273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and Safety of Polatuzumab Vedotin Plus Rituximab, Cyclophosphamide, Doxorubicin and Prednisone for Previously Untreated Diffuse Large B-Cell Lymphoma: A Real-World, Multi-Center, Retrospective Cohort Study.
    Zhao P; Zhao S; Huang C; Li Y; Wang J; Xu J; Li L; Qian Z; Li W; Zhou S; Qiu L; Liu X; Chen Y; Jiang Y; Zheng Y; Chen D; Zhou H; Gao Y; Zhang Q; Zhang H
    Hematol Oncol; 2025 Jan; 43(1):e70017. PubMed ID: 39641321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defining the optimum strategy for identifying adults and children with coeliac disease: systematic review and economic modelling.
    Elwenspoek MM; Thom H; Sheppard AL; Keeney E; O'Donnell R; Jackson J; Roadevin C; Dawson S; Lane D; Stubbs J; Everitt H; Watson JC; Hay AD; Gillett P; Robins G; Jones HE; Mallett S; Whiting PF
    Health Technol Assess; 2022 Oct; 26(44):1-310. PubMed ID: 36321689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary Nodal Epstein-Barr Virus-Positive T-Cell/NK-Cell Lymphoma: Real-World Experience.
    Choi DH; Yoon SE; Cho J; Kim SJ; Kim WS
    Acta Haematol; 2024; 147(6):625-633. PubMed ID: 38432198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matching-adjusted indirect comparison of acalabrutinib versus ibrutinib in relapsed/refractory mantle cell lymphoma.
    Cai L; Roos J; Miranda PAP; Liljas B; Rule S; Wang M
    J Med Econ; 2024; 27(1):1552-1557. PubMed ID: 39461001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of primary prophylaxis by pegfilgrastim in diffuse large B-cell lymphoma treated with R-CHOP.
    Kim M; Ahn Y; Ahn HJ; Ha SH; Oh HS; Song JS; Park WS; Yi SW
    Ann Hematol; 2023 Nov; 102(11):3167-3175. PubMed ID: 37599323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing the efficacy and tolerability of PET-guided BrECADD versus eBEACOPP in advanced-stage, classical Hodgkin lymphoma (HD21): a randomised, multicentre, parallel, open-label, phase 3 trial.
    Borchmann P; Ferdinandus J; Schneider G; Moccia A; Greil R; Hertzberg M; Schaub V; Hüttmann A; Keil F; Dierlamm J; Hänel M; Novak U; Meissner J; Zimmermann A; Mathas S; Zijlstra JM; Fosså A; Viardot A; Hertenstein B; Martin S; Giri P; Scholl S; Topp MS; Jung W; Vucinic V; Beck HJ; Kerkhoff A; Unger B; Rank A; Schroers R; Zum Büschenfelde CM; de Wit M; Trautmann-Grill K; Kamper P; Molin D; Kreissl S; Kaul H; von Tresckow B; Borchmann S; Behringer K; Fuchs M; Rosenwald A; Klapper W; Eich HT; Baues C; Zomas A; Hallek M; Dietlein M; Kobe C; Diehl V; ; ; ; ;
    Lancet; 2024 Jul; 404(10450):341-352. PubMed ID: 38971175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology of biopsy-proven glomerulonephritis in the past 25 years in the North-Eastern area of Romania.
    Covic A; Vlad CE; Căruntu ID; Voroneanu L; Hogas S; Cusai S; Florea L; Covic A
    Int Urol Nephrol; 2022 Feb; 54(2):365-376. PubMed ID: 33991297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delphi consensus recommendations on treatment for advanced-stage marginal zone lymphoma in South Korea.
    Kim SJ; Yoon SY; Chua S; Byun H; Kim J; Ng J
    Ann Hematol; 2024 Sep; 103(9):3615-3625. PubMed ID: 39103723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maribavir treatment for resistant cytomegalovirus disseminated disease in kidney transplant recipients: A case-based scoping review of real life data in literature.
    Corcione S; Lupia T; Vita D; Sidoti F; Zanotto E; Solidoro P; Biancone L; Costa C; Balagna R; De Rosa FG
    Transplant Rev (Orlando); 2024 Dec; 38(4):100873. PubMed ID: 39178643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of reclassification of C3 predominant glomerulopathies on diagnostic accuracy, outcome and prognosis in patients with C3 glomerulonephritis.
    Puri P; Walters GD; Fadia MN; Konia M; Gibson KA; Jiang SH
    BMC Nephrol; 2020 Jul; 21(1):265. PubMed ID: 32652953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case diagnosed with IgA nephropathy during a complete remission of minimal change nephrotic syndrome treated with rituximab.
    Nishikawa M; Shimada N; Kurahashi M; Watanabe K; Kanzaki M; Fukuoka K; Asano K
    CEN Case Rep; 2024 Dec; 13(6):561-564. PubMed ID: 38775892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bortezomib in multiple myeloma and lymphoma: a systematic review and clinical practice guideline.
    Reece D; Imrie K; Stevens A; Smith CA;
    Curr Oncol; 2006 Oct; 13(5):160-72. PubMed ID: 22792013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Addition of temsirolimus to chemotherapy in children, adolescents, and young adults with intermediate-risk rhabdomyosarcoma (ARST1431): a randomised, open-label, phase 3 trial from the Children's Oncology Group.
    Gupta AA; Xue W; Harrison DJ; Hawkins DS; Dasgupta R; Wolden S; Shulkin B; Qumseya A; Routh JC; MacDonald T; Feinberg S; Crompton B; Rudzinski ER; Arnold M; Venkatramani R
    Lancet Oncol; 2024 Jul; 25(7):912-921. PubMed ID: 38936378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Light chain only variant of proliferative glomerulonephritis with monoclonal immunoglobulin deposits: a clinicopathological study of three cases.
    Liang S; Liang D; Zhu X; Liang D; Xu F; Tu Y; Zeng C
    J Clin Pathol; 2024 Jul; 77(8):551-556. PubMed ID: 37137693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between skeletal muscle mass and treatment response in patients with diffuse large B-cell lymphoma.
    Sosa-Romero JT; Castillo-Martínez L; Gabutti-Thomas JA; Agreda-Vásquez GP
    Leuk Lymphoma; 2024 Dec; 65(13):1954-1963. PubMed ID: 39091161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Efficacy and safety analysis of the OR-CHOP regimen for the treatment of MCD subtype diffuse large B cell lymphoma in the real-world setting].
    Yin H; Hua W; Shen HR; Wu JZ; Li Y; Wang L; Liang JH; Li JY; Xu W
    Zhonghua Xue Ye Xue Za Zhi; 2024 Sep; 45(9):827-831. PubMed ID: 39414605
    [No Abstract]   [Full Text] [Related]  

  • 18. Lamotrigine versus levetiracetam or zonisamide for focal epilepsy and valproate versus levetiracetam for generalised and unclassified epilepsy: two SANAD II non-inferiority RCTs.
    Marson AG; Burnside G; Appleton R; Smith D; Leach JP; Sills G; Tudur-Smith C; Plumpton CO; Hughes DA; Williamson PR; Baker G; Balabanova S; Taylor C; Brown R; Hindley D; Howell S; Maguire M; Mohanraj R; Smith PE
    Health Technol Assess; 2021 Dec; 25(75):1-134. PubMed ID: 34931602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of cognitive behaviour therapy versus activity management, both delivered remotely, to treat paediatric chronic fatigue syndrome/myalgic encephalomyelitis: the UK FITNET-NHS RCT.
    Crawley E; Anderson E; Cochrane M; Shirkey BA; Parslow R; Hollingworth W; Mills N; Gaunt D; Treneman-Evans G; Rai M; Macleod J; Kessler D; Pitts K; Cooper S; Loades M; Annaw A; Stallard P; Knoop H; Van de Putte E; Nijhof S; Bleijenberg G; Metcalfe C
    Health Technol Assess; 2024 Oct; 28(70):1-134. PubMed ID: 39485730
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.